Expression of Ki-67 in Breast Cancer Cases – A Study

Article Sidebar

PDF
Published: Jan 11, 2023
Keywords:
phenotype breast cancer prognostic lymph node clinical parameters menopausal status

Main Article Content

R. A. Langade
Associate professor Department of Pediatrics Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth “Deemed To Be University”, Karad – 415110, Maharashtra
Narendra Porwal
Associate professor Department of Pediatrics Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth “Deemed To Be University”, Karad – 415110, Maharashtra
Beemarapu Venkata Sudheer
P.G. Student Department of Pediatrics Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth “Deemed To Be University”, Karad – 415110, Maharashtra

Abstract

In the course of tumor development, the phenotypic of breast cancer constantly changes. Breast cancer is a clinically and biologically/pathologically heterogeneous illness, and this may be a contributing factor. It is crucial to have accurate prognostic data when counseling patients and formulating treatment strategies. While factors like age and menopausal status can be used as prognostic indicators in clinical parameters, crucial prognostic indicators in histology include tumour size and extent, histological type, histological grade, and the presence or absence of lymph node involvement.

Article Details

How to Cite
Langade, R. A., Porwal, N. ., & Venkata Sudheer, B. . (2023). Expression of Ki-67 in Breast Cancer Cases – A Study. Journal of Coastal Life Medicine, 11(1), 1490–1496. Retrieved from https://www.jclmm.com/index.php/journal/article/view/547
Issue
Vol. 11: Number 1, 2023
Section
Articles

References

Bhagat VM. Jha BM, Patel PR. Correlation of hormonal receptor and Her-2/neu expression in breast cancer: A study at tertiary care hospital in south Gujarat. Natl J Med Res. 2012; 2(3):295- 298.

Harrison AP, Srinivasan K, Binu VS, Vidyasagar MS, Nair S. Int J Collab Res Intern Med Public Health. 2010; 2(4):109-116.

Leong SPL, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS et al. Is breast cancer the same in disease in Asian and western countries? World J Surg. 2010; 34:2308-2324.

Rosai J, editor. Breast . In: Rosai and Ackerman’s Surgical Pathology, 9 thed . St. Louis : Mosby Elsevier , 2004, 1764-1876 .

Lester SC. The Breast . In: Robbins and Cotran Pathologic Basis of Disease, 8 th ed. Kumar V , Abbas A K , Fausto N , Aster JC , editors. Philadelphia : Saunders , 2010, 1065-97 .

Douglas H, Weinberg R (2000) The hallmarks of cancer.Cell 100:57-70

Taylor CR, Shi SR. Techniques of immunohistochemistry: Principles, pitfalls and standardization. In: Dabbs DJ ed. Diagnostic Immunohistochemistry Thernostic and Genomic Applications. 4thed. Philadelphia: Elsevier; 2014:1 - 2.

Javed A, Lteif A. Development of the human breast. SeminPlast Surg. 2013; 27(1):5-12.

Larsen WJ. Development of the Integumentary System. In: Human Embryology. 2nded. New York: Churchill Livingstone Inc:1997: 455-470.

Osborne MP, Boolbol SK. Breast anatomy and development. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Disease of the breast. 5thed. Philadelphia: Wolters Kluwer ; 2014: 3-5.

Garg K, Mittal PS, Chandrupatla M. Pectoral region. In: B. D.Chaurasia's Human Anatomy Volume 1. 6th ed. New Delhi: CBS Publishers & Distributors Pvt. Ltd; 2013: 32-45.

Schnitt SJ, Collins LC. Normal anatomy and histology. In: Biopsy Interpretation of The Breast. 2nded. Philadelphia: Lippincott Williams & Wilkins; 2013. 1-24.

Rosai J. Breast. In: Houston M, Scott J, editors. Rosai and Ackerman's Surgical Pathology. 10thed. China: Elsevier; 2011: 1660-1661.

Hoda SA. Anatomy and physiologic morphology. In: Hoda SA, Brogi E, Koerner FC, Rosen PP,editors. Rosen's Breast Pathology. 4th ed. Philadelphia: Lippincott Wilkins; 2014: 1-26

Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer, 2007;7 (10):791-799.

Lakhani SR, Ellis. I.O., Schnitt, S.J., Tan, P.H., van de Vijver, M.J. WHO classification of tumours of the breast. International Agency for Research on Cancer, Lyon, 2012

Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004. Cancer Epidemiol Biomarkers Prev, 2009;18 (6):1763-1769.

Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature, 2000;406 (6797):747-752.

Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A, 2001;98 (19):10869-10874.

Schnitt SJ. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol, 2010;23(2):S60-64.

Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res, 2015;5 (10):2929-2943.

Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Prim. 2019;5(1):66.

Lukong KE. Understanding breast cancer – The long and winding road. BBA Clin. 2017;7(1):64-77.